Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Deferiprone

EU orphan designation number: EU/3/10/832   
Active ingredient: Deferiprone
Indication: Treatment of sickle cell disease
Sponsor: Apotex Europe B.V.
Darwinweg 20, NL- 2333 CR Leiden, Nederland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/03/2011 Centralised Orphan - Designation EMA/OD/077/10 (2011)1298 of 23/02/2011